Published: 18/03/2009 - PDF Version (117 KB)
Frankincense oil - a potential treatment option for bladder cancer
An enriched extract of the Somalian Frankincense herb Boswellia carteri has been shown to kill off bladder cancer cells. Frankincense oil is prepared from aromatic hardened gum resins obtained by tapping Boswellia trees. One of the main components of frankincense oil is boswellic acid, a component known to have anti-neoplastic properties. Research presented in the peer reviewed journal, BMC Complementary and Alternative Medicine found that Frankincense oil might represent an alternative intravesical agent for bladder cancer treatment.
HK Lin and his team, from the University of Oklahoma Health Sciences Center and Oklahoma City VA Medical Center, set out to evaluate frankincense oil for its anti-tumour activity in bladder cancer cells. The authors investigated the effects of the oil in two different types of cells in culture: human bladder cancer cells and normal bladder cells. The team found that frankincense oil is able to discriminate between normal and cancerous bladder cells in culture, and specifically kill cancer cells.
Within a range of concentration, frankincense oil suppressed cell viability in bladder transitional carcinoma J82 cells but not in UROtsa cells. Comprehensive gene expression analysis confirmed that frankincense oil activates genes that are responsible for cell cycle arrest, cell growth suppression, and apoptosis in J82 cells. However, frankincense oil-induced cell death in J82 cells did not result in DNA fragmentation, a hallmark of apoptosis.
Article: Frankincense oil derived from Boswellia carteri induces tumor cell specific cytotoxicity
Mark Barton Frank, Qing Yang, Jeanette Osban, Joseph T Azzarello, Marcia R Saban, Ricardo Saban, Richard A Ashley, Jan C Welter, Kar-Ming Fung and Hsueh-Kung Lin http://www.biomedcentral.com/bmccomplementalternmed/
20/03/2009 11:12:30
Comment by Stuart
Presumably the word "intravesical" means intoduced directly into the bladder, and so is a surgical treatment, and not something that can be administered by the patient him/herself?
20/03/2009 11:12:55
Comment by ecancer
Yes, likely delivered through a catheter.
08/05/2009 12:59:03
Comment by a reader
Is this treatment available in China?

Intensive chemotherapy may be harmful to most older patients with AML
New molecular marker could predict if breast cancer patients need chemotherapy
CTC screening for colorectal cancer not cost-effective when reimbursed at same rate as colonoscopy
Women in their forties have lower mammographic tumour detectability
Genetic risk score associated with breast cancer risk
New roundtable debate: communicating risk in familial cancer
Study finds that the GRB7 gene drives an aggressive form of the disease
ASCO updates guideline on adjuvant hormonal therapy for breast cancer
NICE guideline set to improve care of cancer patients with unknown primary